# Fresenius Medical Care North America

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/fresenius-medical-care-north-america/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Waltham, United States |
| OpenAlex ID | https://openalex.org/F4320316014 |
| ROR ID | https://ror.org/02avws951 |
| Works | 1,810 |

## Funder papers

- [A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease](https://scholariq.org/papers/a-comparative-post-hoc-analysis-of-finerenone-and-spironolactone-in-resistant/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis](https://scholariq.org/papers/spironolactone-in-patients-on-chronic-haemodialysis-at-high-risk-of-adverse/)
- [European Nephrologists’ Attitudes toward the Application of Artificial Intelligence in Clinical Practice: A Comprehensive Survey](https://scholariq.org/papers/european-nephrologists-attitudes-toward-the-application-of-artificial/)
- [International variations in chronic kidney disease patients’ pain experience and its management](https://scholariq.org/papers/international-variations-in-chronic-kidney-disease-patients-pain-experience-and/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.